Valuing life, Granting advanced therapies to patients
Developing and bringing to market enabling technologies, that can ensure the availability and quality of life-saving advanced therapies
Recognizing the need for smart, adaptive automation and understanding that processes constantly evolve, we created the ADVA X3® — a fully controlled, flexible, and automated cell processing platform that transforms how cell therapies are manufactured.
Powered by our proprietary CAMP® (Continuous Adaptive Multi-Parameter) technology, the ADVA X3® seamlessly supports a wide range of applications, including CAR-T, TCR, TIL, NK, Exosomes, Viruses, and more — all within one integrated system.
What truly sets the platform apart is its AI- and Machine Learning–driven intelligence. By combining automation with real-time predictive insights, the ADVA X3® empowers smarter decisions, accelerates processes, and ensures greater reliability and scalability — from development to clinic.
Behind this innovation stands the Adva Biotechnology team — a passionate group of biologists, biotechnologists, and engineers who bring their expertise and creativity to shape the future of advanced cell therapies.
Have any questions? Reach out to us from our contact form and we will get back to you shortly.